Katrin Richter, Nilay Asci, Vijay K Singh, Sanaria Hawro Yakoob, Marion Meixner, Anna Zakrzewicz, Juliane Liese, Andreas Hecker, Sigrid Wilker, Sabine Stumpf, Klaus-Dieter Schlüter, Marius Rohde, Axel Gödecke, Winfried Padberg, Ivan Manzini, Günther Schmalzing, Veronika Grau
OBJECTIVE: The pro-inflammatory cytokine interleukin-1β (IL-1β) plays a central role in host defense against infections. High systemic IL-1β levels, however, promote the pathogenesis of inflammatory disorders. Therefore, mechanisms controlling IL-1β release are of substantial clinical interest. Recently, we identified a cholinergic mechanism inhibiting the ATP-mediated IL-1β release by human monocytes via nicotinic acetylcholine receptor (nAChR) subunits α7, α9 and/or α10...
2023: Frontiers in Immunology